Blog

Dirty Tricks Threaten Medicare Advantage

Read More »

May 29, 2024 No Comments

Democrats Should Join the Call for FDA to Accelerate Approval of Smokefree Products

Read More »

April 24, 2024 No Comments

TPA Weighs in On FDA and Section 230 Congressional Hearings

Read More »

April 10, 2024 No Comments

New Medicare Advantage Rule Threatens Beneficiary Choice and Affordability

Read More »

March 20, 2024 No Comments

Bill of the Month — February 2024: The FDA Modernization Act 3.0

Read More »

February 29, 2024 No Comments

TPA Submits Comments on NIST’s Draft March-In Guidance

Read More »

February 7, 2024 No Comments

If Government Must Be Involved With Healthcare, Let There Be Competition

Read More »

January 29, 2024 No Comments

TPA Statement on FDA Approval of Gene Therapies for Sickle Cell Disease

Read More »

December 11, 2023 No Comments

TPA Slams Biden Administration’s Proposed Overreach in Drug Patents

Read More »

December 7, 2023 No Comments

FDA’s Menthol and Cigar Ban is Bad for Consumers and Health

Read More »

November 17, 2023 No Comments